TP53 and ovarian carcinoma: According to the 2014 NCCN guidelines for multi-gene testing, women with mutations in the non-BRCA genes, such as TP53, PTEN, CDH1, ATM, CHEK2, or PALB2 tumor suppressor genes and others also have an increased risk of breast and ovarian cancer (2, 6).